Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
LLYLilly (Eli)
FinDog View：Bullish
| Metric | CRL | LLY |
|---|
| Close | 273.41 | 1,137.82 |
| Market Cap | $13.1B | $1.07T |
| 1M | −4.62% | −3.83% |
| P/E (TTM) | — | 39.9 |
| Forward P/E | 24.2 | 28.5 |
| P/E 5-Yr Percentile | — | 6 |
| P/S | 3.3 | 13.4 |
| P/B | 4.6 | 31.5 |
| Dividend Yield | — | 0.75% |
| Latest Quarter Revenue | $1.0B | $23.0B |
| Revenue YoY | −2.7% | +47.7% |
| Gross Margin | — | 85.8% |
| Latest Quarter EPS | -0.03 | 7.94 |
| Avg Post-Earnings Move | ±1.8% | ±3.5% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.48% | 1.12% |
| 90-Day Net Insider Buying | −$42.6M | −$16.0M |
CRL · Revenue, Last 8 Quarters ($B)
LLY · Revenue, Last 8 Quarters ($B)
